Arkolith/Insider Trading/INM/Form 4

Adams Eric A

President & CEO, DirectorInMed Pharmaceuticals Inc. (INM) · full profile →Form 4 · filed Apr 18, 2022
Net Buying
Open-Market Buys
$13K
Open-Market Sells
$0
Net Open-Market Flow
$13K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 14, 2022Buy(P)14K$0.89$13K59K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-020314) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML